SCHEMBL25848271

SCHEMBL25848271

C=C(C)C(=O)OC1CCC(Oc2ccc3cc(-c4ccc(OC)cc4C)c(=O)oc3c2)C1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 7/20 0.42
ALDH1A1 P00352 5/20 0.42
HPGD P15428 5/20 0.42
GAA P10253 4/20 0.42
RAB9A P51151 5/20 0.41
NPC1 O15118 4/20 0.41
KDM4E B2RXH2 4/20 0.40
HSD17B10 Q99714 2/20 0.40
SLC16A3 O15427 1/20 0.40
MAOA P21397 2/20 0.39
GLA P06280 2/20 0.39
CA12 O43570 1/20 0.39
CA2 P00918 1/20 0.39
CA3 P07451 1/20 0.39
CA4 P22748 1/20 0.39
CA6 P23280 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
TP53 P04637 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22624956 0.88 MAOB (0.40) MAOBALDH1A1HPGDGAARAB9A
SCHEMBL25848270 0.88 RAB9A (0.41) MAOBALDH1A1HPGDGAARAB9A
SCHEMBL25848273 0.87 MAOB (0.39) MAOBALDH1A1HPGDGAARAB9A
SCHEMBL25848258 0.86 MAOB (0.37) MAOBALDH1A1HPGDGAARAB9A
SCHEMBL25848250 0.84 NPC1 (0.56) MAOBALDH1A1HPGDGAARAB9A
SCHEMBL25848297 0.84 MAOB (0.41) MAOBALDH1A1HPGDGAARAB9A
SCHEMBL25848251 0.83 RAB9A (0.43) MAOBALDH1A1HPGDGAARAB9A
SCHEMBL25848269 0.81 KDM4E (0.39) MAOBALDH1A1HPGDGAARAB9A
SCHEMBL25849401 0.80 MAOB (0.40) MAOBALDH1A1HPGDGAARAB9A
SCHEMBL25848256 0.79 NPC1 (0.35) MAOBALDH1A1HPGDGAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702396-B2 Hydrophobic compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702396-B2 Hydrophobic compounds for optically active devices UACA, CRYZ, TRPA1 MAOB 3207/4885ALDH1A1 1851/4885HPGD 189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.